Accéder au contenu
Merck

TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.

Cell reports (2018-11-01)
Robert M Witwicki, Muhammad B Ekram, Xintao Qiu, Michalina Janiszewska, Shaokun Shu, Mijung Kwon, Anne Trinh, Elizabeth Frias, Nadire Ramadan, Greg Hoffman, Kristine Yu, Yingtian Xie, Gregory McAllister, Rob McDonald, Javad Golji, Michael Schlabach, Antoine deWeck, Nicholas Keen, Ho Man Chan, David Ruddy, Tomas Rejtar, Sosathya Sovath, Serena Silver, William R Sellers, Zainab Jagani, Michael D Hogarty, Charles Roberts, Myles Brown, Kimberly Stegmaier, Henry Long, Ramesh A Shivdasani, David Pellman, Kornelia Polyak
RÉSUMÉ

Perturbed epigenomic programs play key roles in tumorigenesis, and chromatin modulators are candidate therapeutic targets in various human cancer types. To define singular and shared dependencies on DNA and histone modifiers and transcription factors in poorly differentiated adult and pediatric cancers, we conducted a targeted shRNA screen across 59 cell lines of 6 cancer types. Here, we describe the TRPS1 transcription factor as a strong breast cancer-specific hit, owing largely to lineage-restricted expression. Knockdown of TRPS1 resulted in perturbed mitosis, apoptosis, and reduced tumor growth. Integrated analysis of TRPS1 transcriptional targets, chromatin binding, and protein interactions revealed that TRPS1 is associated with the NuRD repressor complex. These findings uncover a transcriptional network that is essential for breast cancer cell survival and propagation.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps monoclonal anti-α-tubuline antibody produced in mouse, clone DM1A, ascites fluid
Sigma-Aldrich
Anticorps anti-phospho-histone H3 (Ser10), marqueur mitotique, Upstate®, from rabbit
Sigma-Aldrich
Anti-MMP-1 Antibody, hinge region, from rabbit, purified by affinity chromatography